Interferon (IFN)-β is a major component of innate immunity in mammals, but information on 27 the in vivo source of this cytokine after pathogen infection is still scarce. To identify the cell 28 types responsible for IFN-β production during viral encephalitis, we used reporter mice that 29 express firefly luciferase under control of the IFN-β promoter and stained organ sections with 30 luciferase-specific antibodies. Numerous luciferase-positive cells were detected in regions of 31 La Crosse virus (LACV)-infected mouse brains that contained many infected cells. Double 32 staining experiments with cell-type specific markers revealed that similar numbers of 33 astrocytes and microglia of infected brains were luciferase-positive, whereas virus-infected 34 neurons rarely contained detectable levels of luciferase. Interestingly, if a mutant LACV 35 unable of synthesizing the IFN-antagonistic factor NSs was used for challenge, the vast 36 majority of the IFN-β-producing cells in infected brains were astrocytes rather than microglia. 37 Similar conclusions were reached in a second series of experiments in which conditional 38 reporter mice expressing the luciferase reporter gene solely in defined cell types were infected 39 with wild-type or mutant LACV. Collectively, our data suggest that glial cells rather than 40 infected neurons represent the major source of IFN-β in LACV-infected mouse brains. They 41 further indicate that IFN-β synthesis in astrocytes and microglia is differentially affected by 42 the viral IFN antagonist, presumably due to differences in LACV susceptibility of these two 43 cell types. 44 45 Visualizing of IFN-β in LACV-infected mouse brains 3
Introduction 46
Viruses can trigger pattern recognition receptors of infected hosts which initiate signaling 47 cascades that culminate in transcriptional activation of type I and type III interferon (IFN) 48 genes. Type I and type III IFNs are cytokines that use distinct receptor complexes for 49 signaling and which, thereby, induce an antiviral state in uninfected cells. The family of type I 50 IFN includes more than ten different IFN-α subtypes, IFN-β and minor subtypes such as ω or IFN-δ, whereas type III IFN includes 19 ). These various IFN 52 genes are typically co-induced in response to virus infection, although the kinetics and the 53 degree of activation of the different IFN genes differ considerably depending on producer cell 54 type and nature of challenge virus (6, 15) . In the mouse, IFN-β is the first type I IFN subtype 55 being expressed after viral infection and, together with IFN-α4, is considered to prime cells 56 for the production of other type I IFN family members (2). 57
Pattern recognition receptors which can recognize RNA viruses include cytoplasmic RIG-like 58 helicases and membrane-anchored toll-like receptors (TLR). Cell culture studies indicate that 59 most if not all nucleated mammalian cells can synthesize IFN in response to signals from 60 RIG-like helicases when infected with replication-competent viruses (21) . Further, certain 61 immune cells such as macrophages and dendritic cells readily synthesize IFN when receiving 62 signals from TLRs which recognize engulfed virus-derived nucleic acids (14) . The situation 63 after infection of an intact organism is much more complex. For viruses that cause viremia, 64 plasmacytoid dendritic cells (pDC) which are mainly present in blood and spleen of mammals 65 are responsible for most of the circulating IFN (1, 7, 24) . During influenza virus infection of 66 the lung, pDC seem to play far less important roles (12) . Similarly, classical immune cells 67 including pDCs are not present in healthy brains (10, 13) , suggesting that other cell types are 68 mainly responsible for IFN synthesis in this organ. However, previous attempts to 69 unambiguously identify these alternative IFN-producing cells did not yield a clear picture. 70
Experiments were either performed with isolated brain cells or were focused on certain cell 71 types without addressing the question of the contribution of such cells to the overall IFN-72 response in the central nervous system (10, 22, 23, 26) . One difficulty with these experimental 73 approaches was that IFNs are quickly secreted and are not accumulating to high intracellular 74 levels in producer cells, thus complicating their detection in tissue slices by La Crosse virus (LACV) is a mosquito-borne pathogen that infects up to 300,000 people in 77 the United States and can cause encephalitis in children and young adults (3). LACV belongs 78 to the genus Orthobunyavirus, family Bunyaviridae. These viruses have a tri-segmented 79
Visualizing of IFN-β in LACV-infected mouse brains 4 single-stranded RNA genome of negative polarity and replicate in the cytoplasm of infected 80 cells. The smallest genome segment of LACV codes for the viral nucleoprotein and a non-81 structural protein, termed NSs, which efficiently inhibits the IFN system of infected 82 mammalian hosts. NSs of LACV induces degradation of cellular RNA polymerase II which, 83 in turn, results in reduced transcription of many cellular genes, including the genes for type I 84 and type III IFN (27) . A mutant of LACV lacking a functional NSs gene (LACV-ΔNSs) was 85 generated (5). As expected if NSs served as IFN antagonist, LACV-ΔNSs induced 86 significantly more IFN in cultured cells and brains of infected mice than wild-type LACV (4, 87 18). Further, the LACV-ΔNSs mutant was less virulent than wild-type LACV in mice, 88 although both viruses cause encephalitis and death after 5-10 days if administered 89 intraperitoneally into juvenile mice (4). Using conventional in situ hybridization and 90 immunostaining techniques, we previously identified cells with macrophage and ependymal 91 markers as major sources of IFN-α and -β in the brain of mice with acute LACV encephalitis, 92 and we observed that neurons represent a minor but substantial source of IFN during viral 93 encephalitis (10). 94 Transgenic mice in which reporter genes were inserted into the coding regions of the IFN-α or 95 -β genes are promising new tools for studying virus-induced expression of IFN genes in vivo. 96 A reporter mouse which expresses green-florescent protein (GFP) in place of IFN-α6 was 97 successfully used to demonstrate that alveolar macrophages contribute to IFN synthesis in 98 virus-infected lungs (17). Cells from a reporter mouse with a modified IFN-β locus encoding 99 GFP were used to demonstrate the stochastic nature of type I IFN gene expression (28). We 100 recently employed another reporter mouse in which the IFN-β coding region is replaced by 101 luciferase to visualize IFN synthesis in virus-infected animals by in vivo imaging (18). We 102 now used the same luciferase reporter mouse to analyze the contribution of various brain cell 103 types to IFN-β synthesis in mice with LACV encephalitis. We visualized IFN-β-producing 104 cells by staining brain sections with antibodies that simultaneously recognize luciferase and 105 marker proteins of neurons, astrocytes and microglia, respectively. We further took advantage 106 of the possibility that the loxP-flanked luciferase gene in this reporter mouse can be 107 rearranged in defined cell types by crossing these animals with mice that express Cre 108 recombinase in a cell type-specific manner. Using these two approaches we identified 109 astrocytes and microglia as the main IFN-β producers in LACV-infected brains. We further 110 observed that the LACV-encoded IFN-antagonistic factor NSs strongly impairs IFN 111 production by astrocytes but not microglia. 112 113 Visualizing of IFN-β in LACV-infected mouse brains 5
Materials and Methods 114
Mice: Mice were bred in the animal facility of the Department of Virology at the University 115 of Freiburg. All mice used in this study were on the C57BL/6 background, or backcrossed 116 onto C57BL/6 for at least 5 generations. IFN-β +/Δβ-luc and conditional reporter IFN-β +/floxβ-luc 117 mice have been described previously (18, 25) . IFN-β floxβ-luc/floxβ-luc mice were crossed to 118 LysM-Cre (25), Thy1-Cre (11) (Jackson Lab, Stock Number 006143) and Synapsin1-Cre 119 mice (29) to generate mice that express the reporter gene either in microglia and 120 macrophages, astrocytes and neurons, and neurons, respectively. 121
122
Viruses and infection of mice: Wild-type LACV and mutant LACV-ΔNSs that cannot express 123 the IFN antagonistic factor NSs were previously described (5). Virus stocks were generated in 124 Vero cells. Juvenile mice (12-15 days old) were infected intraperitonally with 10 4 plaque 125 forming units (PFU) of wild-type or mutant LACV diluted in 100 µl of phosphate buffer 126 saline (PBS). Animals were sacrificed soon after onset of neurological symptoms. Brains 127 were either collected without fixation for virus titration and measuring luciferase activity or 128 were perfusion fixed for immunohistochemical analyses as described below. 129 130 Virus titrations: Plaque assays were performed in Vero cells using 6-well plates. Serial 131 dilutions of lysates were applied for 1 h. Supernatants were then removed and replaced by a 132 1:1 mixture of 3% Avicel-cellulose (FMC BioPolymer) and double concentrated DMEM 133 (Gibco). Vero cells were incubated for 72 h at 37 °C and 5% CO 2 before supernatants were 134 removed. Cells were fixed with 4% paraformaldehyde, and plaques were visualized by 135 staining with 0.5% crystal violet. Results 160
Identification of IFN-β-producing cells in LACV-infected brains 161
To visualize IFN-β-producing cells in the brain of LACV-infected heterozygous reporter 162 mice, we stained tissue slices from animals exhibiting clinically apparent encephalitis with 163 luciferase-specific antibodies. Because luciferase expression levels were expected to be low 164 and paraffin-or cryo-embedding might affect epitope recognition, we decided to work 165 exclusively with paraformaldehyde-fixed free floating slices prepared by vibratome 166 sectioning. We observed that luciferase signals were very faint if standard histological 167 staining techniques were applied. Consequently, signal amplification was routinely employed 168 for better visualization of IFN-β-producing cells. antibodies that recognize cell type-specific markers. This analysis was performed with both 188 wild-type LACV and the NSs-deficient mutant virus to address the question of whether the 189 IFN-antagonistic factor NSs might act predominantly in certain cell types. In agreement with 190 previous results (4), we found that luciferase levels in brains of mice infected with the ΔNSs 191 virus were about 6-fold enhanced, although the mutant virus replicated substantially less well 192 than wild-type virus with about 30-fold reduced peak brain titers (Fig. 2) . A large number of 193
Visualizing of IFN-β in LACV-infected mouse brains 8 luciferase-positive cells in brains of mice infected with wild-type or NSs-deficient LACV 194 expressed GFAP, indicating that they represent astrocytes ( Fig. 3A and 3B ). Other luciferase-195 positive cells expressed the macrophage/microglia marker protein F4/80 ( Fig. 3C and 3D) . 196 To make this analysis more quantitative, we compiled the results from a detailed inspection of 197 tissue slices from three or more severely diseased animals per virus strain. At least 300 198 luciferase-positive cells were evaluated individually for each double-staining experiment 199 listed in table 1. In brains of mice infected with the LACV-ΔNSs mutant, the vast majority 200 (89%) of luciferase-positive cells expressed GFAP, suggesting that they represent astrocytes. 201
The F4/80 marker which is present on microglia and infiltrating macrophages was expressed 202 by approximately 5% of the luciferase-positive cells in brains of mice infected with LACV-203
ΔNSs. The number of luciferase-positive cells expressing NeuN was approximately 1%, 204 suggesting that only very few neurons can synthesize large amounts of IFN-β. A strikingly 205 different picture emerged when the staining data from wild-type LACV-infected mice were 206 compiled. In this case, the frequency of luciferase-positive astrocytes was only 35%, whereas 207 the frequency of luciferase-positive microglia/macrophages was 62% (Table 1) To confirm the results obtained by immunohistochemistry, we created reporter mice in which 213 luciferase is expressed exclusively in predetermined cell types. Such animals may be 214 generated by breeding reporter mice which contain strategically positioned loxP sites with 215 mice that selectively express Cre recombinase in defined cell types (25) . For the current study 216 we used Synapsin1-Cre mice to generate animals in which expression of luciferase is 217 restricted to neurons (29). Further, we used Thy1-Cre mice to produce reporter mice which 218 express luciferase in both neurons and astrocytes (11). Finally, we employed LysM-Cre mice 219 to generate reporter mice in which luciferase expression is restricted to microglia and 220 macrophages (9, 20) . 221
To verify the predicted luciferase gene expression patterns in our conditional reporter mice we 222 performed double-staining experiments of brain sections from LACV-infected LysM-Cre or 223
Thy1-Cre reporter mice with antibodies recognizing luciferase and the corresponding markers 224 F4/80 and GFAP. As expected if the reporter mice expressed the luciferase gene with desired 225 cell type specificity, we found that luciferase-positive cells in brains of infected LysM-Cre 226 mice expressed F4/80, an antigen of microglia and macrophages (Fig. 4A) , but not the 227 Visualizing of IFN-β in LACV-infected mouse brains 9 astrocyte marker GFAP (data not shown). Similarly, the luciferase-positive cells observed in 228 brains of Thy1-Cre mice expressed GFAP (Fig. 4B ), but not F4/80 (data not shown). Further, 229 as expected if the Synapsin-Cre reporter mice expressed the luciferase transgene exclusively 230 in neurons, we failed to detect any luciferase-positive cells in brain areas of such mice which 231 were strongly infected with LACV, excluding accidental recombination in cell types others 232 than neurons (Fig. 4C) . Thus, the conditional reporter mice used here represent suitable tools 233 for the assessment of the relative contributions of the various cell types to overall IFN 234 synthesis in LACV-infected brains. 235
Since luciferase expression is driven by the virus-inducible IFN-β promoter in our mice, a 236 direct comparison of reporter gene activity in individual animals will only yield meaningful 237 quantitative data if virus replication in brains is similar. Although the different conditional 238 reporter mice showed no significant differences in onset of symptoms or course of disease 239 ( Fig. 5) , we tried to minimize errors resulting from any variation in viral titers by restricting 240 this comparison to animals containing matching viral brain titers (~8x10 6 pfu in the case of 241 LACV-ΔNSs and ~1x10 8 pfu in the case of LACV-wt). Under these experimental conditions, 242 "global" Δβ-luc mice infected with LACV-ΔNSs contained, at average, 5x10 5 RLU of 243 luciferase activity per µl of brain extract (Fig. 6A ). Luciferase activity in brain extracts from 244 Thy1-Cre mice infected with LACV-ΔNSs was only slightly reduced, suggesting that at least 245 71.4% of the luciferase signal originates from virus-mediated stimulation of astrocytes and 246 neurons (Fig. 6B ). Luciferase activity in extracts from brains of Synapsin1-Cre mice was 247 9.4% of "global" mice, whereas luciferase activity in extracts of brains from LysM-Cre mice 248 infected with LACV-ΔNSs was comparatively low. If compared to "global" mice, the signal 249 in LysM-Cre mice was only about 1.7% at average (Fig. 6B) . Thus, astrocytes, neurons and 250 microglia together accounted for ~75% of luciferase activity of "global" reporter mice. The 251 cellular origin of the missing ~25% of activity (white sector in Fig. 6B ) remains unclear. It 252 most likely indicates incomplete Cre-mediated recombination of the lox-P-tagged target gene 253 in our mice. 254 A different picture emerged when LACV-wt was used for the infection study. First, as 255 discussed above, luciferase activity in brain extracts of "global" mice infected with LAVC-wt 256 was about 6-fold lower than in "global" mice infected with LACV-ΔNSs and, at average, 257 reached values of only 9x10 4 RLU per µl of brain extract (Fig. 6C) . Second, compared to 258 infection with LACV-ΔNSs, luciferase activity in brains of wild-type LACV-infected LysM-259 Cre mice was significantly increased. At average, it accounted for 41.4% of the signal 260 observed in "global" mice infected with wild-type LACV (Fig. 6D) . Third, the contribution of 261 neurons to overall luciferase activity did not differ substantially in mice infected with either 262 wild-type or mutant LACV, whereas the contribution of astrocytes was clearly less prominent 263 in wild-type LACV-infected mice compared to mice infected with the ΔNSs mutant virus 264 ( Fig. 6D) . Thus, our experiments with the conditional reporter mice could confirm the 265 conclusions from our double-staining experiments with the "global" reporter mice which 266 suggested that the two virus variants induce a strikingly different cellular IFN-β expression 267 pattern. 268 269 270
Discussion 271
Employing transgenic mice that express a luciferase reporter gene under control of the IFN-β 272 promoter we established a staining protocol that can identify single IFN-β-producing cells in 273 virus-infected brain tissue. To quantify the relative contribution of specific cell types to 274 overall IFN-β synthesis in the brain, we took advantage of the Cre-Lox system and generated 275 reporter mice that express the luciferase transgene either in astrocytes and neurons, neurons 276 only, or microglia and macrophages. When using La Crosse virus as a model for viral 277 encephalitis, we found that astroyctes and microglia were the main producers of IFN-β in the 278 infected brain, whereas the contribution of infected neurons was relatively small. 279
Interestingly, when a mutant virus was used for challenge that cannot synthesize the IFN-280 antagonistic factor NSs, the balance was shifted and astrocytes became the dominant IFN-β 281 producers. Our work demonstrates that besides infected cells, seemingly uninfected cells also 282 contribute massively to IFN synthesis in the central nervous system. Our work further 283 demonstrates that virus-encoded antagonistic factors can affect IFN production by acting 284 selectively on distinct cell types. 285
Previous attempts to characterize the production of IFN during viral encephalitis by in situ 286 hybridization technology had already indicated that various cell types, including neurons, 287 contain detectable levels of type I IFN (10). These authors had used specific antisera to 288 visualize IFN-α-and IFN-β-producing cells in virus-infected brains. However, signals were 289 weak, and quantitative analyses were depended on visual interpretation of histological data. 290
This difficulty presumably originates from the fact that type I IFN is quickly secreted from 291 producer cells and fails to accumulate to high intracellular levels, thus complicating detection 292 by immunostaining. The reporter mice that we used in this study overcome this problem as 293 the luciferase molecule lacks export signals and thus accumulates in the cytoplasm of the 294 producer cells. Nevertheless, staining of tissue for luciferase in virus-infected reporter mice 295
Visualizing of IFN-β in LACV-infected mouse brains 11 was challenging as standard histological protocols failed to produce detectable signals. We 296 could eventually overcome these problems by using mild conditions for sectioning and 297 staining, and by including a signal amplification step. 298
Our immunostaining approach is backed-up well by results from experiments with conditional 299 reporter mice that express the IFN-β-promoter-regulated luciferase gene exclusively in 300 defined cell types. We stringently evaluated the possibility that the Cre recombinase worked 301 non-specifically in these mice and that reporter gene expression by undesired cell types 302 clouded the picture. Our immunostaining experiments yielded no evidence that this was the 303 case. Rather, as predicted, LysM promoter-driven expression of Cre recombinase seemed to 304 rearrange the IFN-β locus exclusively in cells that were positive for the microglia/macrophage 305 marker F4/80. Similarly, Thy1 promoter-driven expression of Cre recombinase seemed to 306 activate the loxP-tagged reporter gene only in astrocytes and presumably neurons. Evidence 307 that Synapsin1-driven expression of Cre recombinase resulted in selective rearrangement of 308 the loxP-tagged IFN-β locus in neurons is indirect. By immunostaining we failed to observe 309 luciferase-positive cells in brain areas of LACV-ΔNSs-infected Synapsin1-Cre mice in which 310 viral antigen was abundantly present. If the locus had by accident also been rearranged in 311 astrocytes or microglia, we would have observed distinct luciferase-positive cells in such 312
brains. 313
Comparing the results of our immunostaining experiments with the results of our Cre-loxP 314 approach showed a very good correlation in the case of astrocytes and microglia, but no clear 315 correlation in the case of neurons. This discrepancy can easily be explained by the high 316 detection threshold of the immunostaining technique. Most likely, the IFN-β-promoter-driven 317 luciferase gene got activated to a low extent in LACV-infected neurons, but luciferase levels 318 in individual cells remained too low for detection by antibody staining. Since a large 319 percentage of neurons got productively infected with LACV in our mice, it is likely that the 320 small contribution of individual neurons did add up considerably. These considerations may 321 explain why experiments with our Synapsin1-Cre reporter mice indicated a more substantial 322 contribution of neurons to luciferase activity in LACV-infected brains than the histological 323
analysis. 324
A remarkable finding of our study was that astrocytes contribute substantially to IFN 325 synthesis in the virus-infected brain. As productive replication of LACV is largely restricted 326 to neurons (4, 10, 16), this result was not expected. Since the contribution of astrocytes was 327 much more pronounced if a mutant LACV was used for infection that cannot synthesize the 328 IFN-antagonistic factor NSs, we assume that a high number of brain astrocytes can get 329 infected by LACV, although such infections are presumably mostly non-productive. By 330 contrast, the luciferase signal in microglia was not negatively regulated by NSs. In fact, IFN 331 production by microglia was even higher if wild-type virus was administered instead of 332 LACV-ΔNSs. Therefore, IFN production by microglia correlated directly with the virus load 333 in the brain, irrespective of whether the challenge virus coded for NSs or not. The most 334 coherent explanation of this observation is that, in contrast to astrocytes, IFN production by 335 microglia is not triggered by intracellular virus sensors such as Rig-I but rather by alternative 336 sensors such as toll-like receptors that can detect viral components in the extracellular space. 337
Taken together, our study demonstrates that three cell types are responsible for the bulk of 338 IFN synthesis during acute encephalitis after LACV infection, namely, productively infected 339 neurons, abortively infected astrocytes and uninfected microglia. Interestingly, if not inhibited 340 by the viral IFN-antagonistic factor NSs, the amount of IFN-β expressed by neurons exceeds 341 the quantity of IFN-β produced by microglia and macrophages. In line with these findings, 342 IFN synthesis by astrocytes was also strongly inhibited by the viral IFN-antagonistic factor 343 NSs, whereas microglia proved to be a more robust source of IFN synthesis. 
